Juan Pablo Frias, MD, lists scores on 3 common screening tests (fasting plasma glucose, hemoglobin A1C, and 75g oral glucose tolerance) that indicates someone in an intermediary position between normal...
Ryan Ungaro, MD, of the Icahn School of Medicine at Mt. Sinai in New York, gives a recap of his presentation on treat-to-target in IBD from the virtual Advances in Inflammatory Bowel Disease 2020 regional...
In this video, Raymond Cross, MD, from the University of Maryland, addresses the most challenging extraintestinal manifestations among patients with inflammatory bowel disease.
